G. R. Rayat and R. G. Gill, “Indefinite survival of Neonatal Porcine Islet Xenografts by Simultaneous Targeting of LFA-1 and CD154 or CD45RB,” Diabetes, Vol. 54, No. 2, 2005, pp. 443-451. http://dx.doi.org/10.2337/diabetes.54.2.443

has been cited by the following article:

• TITLE: Allograft Survival without Immunosuppression in Landrace Pigs after 90 Days

  AUTHORS: Rafael Valdés-Gonzalez, Arturo Mundo Acevedo, Ana L. Rodriguez-Ventura, Pedro Valencia Mayoral

  KEYWORDS: Allografts; Collagen-Generator Device

  JOURNAL NAME: Open Journal of Organ Transplant Surgery, Vol.3 No.4, November 4, 2013

  ABSTRACT: Allotransplantation is helpful in order to maintain the life in some cases, but immunosuppression causes collateral effects. In this study, we were reporting the results of allografts in Landrace pigs, which were implanted on collagen-generator devices. After 2 weeks of implantation, the devices were carried out to assess allograft viability at 30, 60 and 90 days post implant. The implanted cells were islets of Langerhans and the aim was to prove their presence by immunohistochemistry for insulin and glucagon. The results were positive at 30, 60 and 90 days post implant. It demonstrated that the collagen-generator device permits the cell viability without using anti-rejected drugs or immunomodulating cells.